Literature DB >> 16281989

Subversion of host cell signalling by the protozoan parasite Leishmania.

D J Gregory1, M Olivier.   

Abstract

The protozoa Leishmania spp. are obligate intracellular parasites that inhabit the macrophages of their host. Since macrophages are specialized for the identification and destruction of invading pathogens, both directly and by triggering an innate immune response, Leishmania have evolved a number of mechanisms for suppressing some critical macrophage activities. In this review, we discuss how various species of Leishmania distort the host macrophage's own signalling pathways to repress the expression of various cytokines and microbicidal molecules (nitric oxide and reactive oxygen species), and antigen presentation. In particular, we describe how MAP Kinase and JAK/STAT cascades are repressed, and intracellular Ca2+ and the activities of protein tyrosine phosphatases, in particular SHP-1, are elevated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16281989     DOI: 10.1017/S0031182005008139

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  48 in total

1.  The Tetrahymena thermophila phagosome proteome.

Authors:  Mary Ellen Jacobs; Leroi V DeSouza; Haresha Samaranayake; Ronald E Pearlman; K W Michael Siu; Lawrence A Klobutcher
Journal:  Eukaryot Cell       Date:  2006-09-29

Review 2.  Leishmaniasis: complexity at the host-pathogen interface.

Authors:  Paul Kaye; Phillip Scott
Journal:  Nat Rev Microbiol       Date:  2011-07-11       Impact factor: 60.633

3.  Leishmania-induced repression of selected non-coding RNA genes containing B-box element at their promoters in alternatively polarized M2 macrophages.

Authors:  Anitra L Farrow; Tanu Rana; Mukul K Mittal; Smita Misra; Gautam Chaudhuri
Journal:  Mol Cell Biochem       Date:  2010-12-17       Impact factor: 3.396

4.  Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania.

Authors:  Djalma S Lima-Junior; Diego L Costa; Vanessa Carregaro; Larissa D Cunha; Alexandre L N Silva; Tiago W P Mineo; Fredy R S Gutierrez; Maria Bellio; Karina R Bortoluci; Richard A Flavell; Marcelo T Bozza; João S Silva; Dario S Zamboni
Journal:  Nat Med       Date:  2013-06-09       Impact factor: 53.440

5.  Characterization of microRNA expression profiles in Leishmania-infected human phagocytes.

Authors:  N S Geraci; J C Tan; M A McDowell
Journal:  Parasite Immunol       Date:  2015-01       Impact factor: 2.280

6.  Tumor suppressor p53 induces apoptosis of host lymphocytes experimentally infected by Leishmania major, by activation of Bax and caspase-3: a possible survival mechanism for the parasite.

Authors:  Mozhgan Moshrefi; Adel Spotin; Hossein Samadi Kafil; Mahmoud Mahami-Oskouei; Behzad Baradaran; Ehsan Ahmadpour; Behzad Mansoori
Journal:  Parasitol Res       Date:  2017-05-30       Impact factor: 2.289

7.  Effector prediction in host-pathogen interaction based on a Markov model of a ubiquitous EPIYA motif.

Authors:  Shunfu Xu; Chao Zhang; Yi Miao; Jianjiong Gao; Dong Xu
Journal:  BMC Genomics       Date:  2010-12-01       Impact factor: 3.969

8.  Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses.

Authors:  Diego A Vargas-Inchaustegui; Lijun Xin; Lynn Soong
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

9.  Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase, ERK.

Authors:  Paola Mercedes Boggiatto; Fei Jie; Mousumi Ghosh; Katherine Nicole Gibson-Corley; Amanda Ellen Ramer-Tait; Douglas Elliot Jones; Christine Anne Petersen
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

10.  Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages.

Authors:  Asha Jayakumar; Robyn Widenmaier; Xiaojing Ma; Mary Ann McDowell
Journal:  J Parasitol       Date:  2008-02       Impact factor: 1.276

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.